Allantoin
Therapeutic agent (verify pharmacological class)
What it is used for
Used topically as a vulnerary to stimulate tissue repair in suppurating wounds, resistant ulcers, acne, seborrhea, cold sore, hemorrhoid and various dermatological infections and psoriasis. Clinical selection for Allantoin should follow culture results where relevant, Kenya STG/EML recommendations, and the current product SmPC. Class context: Therapeutic agent (verify pharmacological class). Confirm site-specific dose, duration and monitoring before prescribing.
Warnings
For external use only . When using this product keep out of eyes. Rinse with water to remove. Stop use and ask a doctor if the condition worsens or symptoms persist for more than 7 days or clear up and occur again within a few days. Do not use on deep or puncture wounds, animal bites, and serious burns.
Possible side effects
Adverse reactions vary by agent. Counsel on common predictable effects and serious warning symptoms (allergy, severe rash, jaundice, unusual bleeding, severe GI symptoms, neurological changes). Report suspected ADRs via national pharmacovigilance channels.
Storage
Store as labelled. Keep out of reach of children.
No reviewed patient-education article is available. The fields shown are from the currently verified medicine record and unavailable fields are not inferred.